NasdaqCM - Delayed Quote • USD
Dermata Therapeutics, Inc. (DRMA)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 6:27 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -3.79 | -3.73 | -16.17 | -4.61 |
| Low Estimate | -3.79 | -3.73 | -16.17 | -4.61 |
| High Estimate | -3.79 | -3.73 | -16.17 | -4.61 |
| Year Ago EPS | -9.45 | -8.1 | -40.05 | -16.17 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -13.8 | -9.45 | -11.7 | -5.4 |
| EPS Actual | -9.45 | -8.1 | -3.15 | -7.05 |
| Difference | 4.35 | 1.35 | 8.55 | -1.65 |
| Surprise % | 31.50% | 14.30% | 73.10% | -30.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -3.79 | -3.73 | -16.17 | -4.61 |
| 7 Days Ago | -3.79 | -3.73 | -16.17 | -4.61 |
| 30 Days Ago | -0.42 | -0.27 | -1.38 | -0.66 |
| 60 Days Ago | -0.42 | -0.27 | -1.38 | -0.66 |
| 90 Days Ago | -0.54 | -0.51 | -2.35 | -1.32 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DRMA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 59.90% | -- | -- | 9.10% |
| Next Qtr. | 54.00% | -- | -- | 11.50% |
| Current Year | 59.60% | -- | -- | 5.70% |
| Next Year | 71.50% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.34% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Maxim Group: Buy | 3/23/2023 |
Related Tickers
PBLA Panbela Therapeutics, Inc.
0.3701
-3.12%
ESLA Estrella Immunopharma, Inc.
0.8990
-3.69%
ENSC Ensysce Biosciences, Inc.
0.5455
+0.06%
PALI Palisade Bio, Inc.
4.5700
-2.56%
PHIO Phio Pharmaceuticals Corp.
0.7450
+0.95%
ALLR Allarity Therapeutics, Inc.
0.5010
-9.71%
CYTO Altamira Therapeutics Ltd.
1.4300
-4.03%
PXMD PaxMedica, Inc.
0.3120
-5.45%
REVB Revelation Biosciences, Inc.
2.2000
-3.08%
NRBO NeuroBo Pharmaceuticals, Inc.
3.9300
-1.26%